Nymox Pharmaceutical Corp
NYMXF- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001018735
No open-market purchases or sales by Nymox Pharmaceutical Corp insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4.21K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Nymox Pharmaceutical Corp as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −3 vs. Q4 2021
- Shares held
- 1.79M
- +211.4K (+13.4%) vs. Q4 2021
- Total value
- $2.25M
- +$200.8K (+9.8%) vs. Q4 2021
- New holders
- 8
- 3 more added
- Sold out
- 11
- 7 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NYMXF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4.21K |
| Q1 2026 | 1 | $2.46K |
| Q4 2025 | 1 | $1.41K |
| Q3 2025 | 1 | $2.06K |
| Q2 2025 | 1 | $4.13K |
| Q1 2025 | 2 | $16.0K |
| Q4 2024 | 1 | $3.51K |
| Q3 2024 | 2 | $13.2K |
| Q2 2024 | 1 | $6.67K |
| Q1 2024 | 3 | $48.0K |
| Q4 2023 | 2 | $26.6K |
| Q3 2023 | 5 | $68.3K |
| Q2 2023 | 36 | $287.4K |
| Q1 2023 | 35 | $575.1K |
| Q4 2022 | 37 | $443.7K |
| Q3 2022 | 34 | $494.6K |
| Q2 2022 | 39 | $590.1K |
| Q1 2022 | 40 | $2.25M |
| Q4 2021 | 43 | $2.05M |
| Q3 2021 | 38 | $4.00M |
| Q2 2021 | 51 | $4.03M |
| Q1 2021 | 59 | $13.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Nymox Pharmaceutical Corp; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 167 | $0 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Steward Financial Group LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 550 | $1.00K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,700 | $2.14K | 0.00% | 00.0% | Unchanged |
| Sterling Investment Advisors, Ltd. | 2,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 8,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 9,626 | $12.0K | 0.00% | −6,760−41.3% | Reduced |
| Bank of America Corp | 9,401 | $12.0K | 0.00% | −5,716−37.8% | Reduced |
| Lincoln National Corp | 10,315 | $13.0K | 0.00% | 00.0% | Unchanged |
| One Day In July LLC | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 11,449 | $14.0K | 0.00% | −632−5.2% | Reduced |
| Kestra Advisory Services, LLC | 11,532 | $15.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 12,240 | $15.0K | 0.00% | +12,240 | New |
| Cubic Asset Management, LLC | 14,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 17,200 | $21.0K | 0.00% | 00.0% | Unchanged |
| Willow Creek Wealth Management Inc. | 18,724 | $24.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 23,905 | $30.0K | 0.00% | −477−2.0% | Reduced |
| Warberg Asset Management LLC | 24,575 | $31.0K | 0.01% | +24,575 | New |
| Gofen & Glossberg LLC | 25,000 | $32.0K | 0.00% | 00.0% | Unchanged |
| Brown Advisory Securities, LLC | 28,000 | $35.0K | 0.02% | 00.0% | Unchanged |
| Credit Suisse AG | 30,000 | $38.0K | 0.00% | 00.0% | Unchanged |
| First Citizens Financial Corp | 35,100 | $44.0K | 0.03% | 00.0% | Unchanged |
| Patriot Financial Group Insurance Agency, LLC | 34,650 | $44.0K | 0.01% | +11,250+48.1% | Added |
| MAI Capital Management | 35,000 | $44.0K | 0.00% | +35,000 | New |
| Group One Trading, L.P. | 36,080 | $45.0K | 0.00% | +35,484+5,953.7% | Added |
| WMS Partners, LLC | 42,000 | $53.0K | 0.01% | +42,000 | New |
| CVI Holdings, LLC | 45,993 | $58.0K | 0.00% | +45,993 | New |
| Geode Capital Management, LLC | 50,678 | $63.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 64,763 | $82.0K | 0.00% | −1,225−1.9% | Reduced |
| Morgan Stanley | 68,274 | $86.0K | 0.00% | +1,174+1.7% | Added |
| DF Dent & Co Inc | 75,000 | $94.0K | 0.00% | +75,000 | New |
| Leonteq Securities AG | 74,999 | $94.5K | 0.00% | 00.0% | Unchanged |
| Murchinson Ltd. | 76,404 | $96.0K | 0.02% | +76,404 | New |
| Webster Bank, N. A. | 80,000 | $101.0K | 0.01% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 85,100 | $107.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 109,079 | $137.0K | 0.00% | +109,079 | New |
| BlackRock Inc. | 135,485 | $171.0K | 0.00% | −175−0.1% | Reduced |
| Federation des caisses Desjardins du Quebec | 466,000 | $587.2K | 0.01% | −35,000−7.0% | Reduced |
| Ergoteles LLC | 0 | $0 | 0.00% | −101,332−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −25,658−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −21,880−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −11,444−100.0% | Sold out |
| Veriti Management LLC | 0 | $0 | 0.00% | −11,315−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −6,109−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −8,417−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −7,478−100.0% | Sold out |
| PSI Advisors, LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Cornerstone Advisory, LLC | 0 | $0 | 0.00% | −4,536−100.0% | Sold out |
| Snowden Capital Advisors LLC | 0 | $0 | 0.00% | −675−100.0% | Sold out |